✦ LIBER ✦
Cost-effectiveness of 3-year vs 1-year adjuvant therapy with imatinib in patients with high risk of gastrointestinal stromal tumour recurrence in the Netherlands; a modelling study alongside the SSGXVIII/AIO trial
✍ Scribed by Majer, I. M.; Gelderblom, H.; van den Hout, W. B.; Gray, E.; Verheggen, B. G.
- Book ID
- 127052198
- Publisher
- Informa plc
- Year
- 2013
- Tongue
- English
- Weight
- 336 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1369-6998
No coin nor oath required. For personal study only.